Magnetic Resonance in Medicine,
Год журнала:
2025,
Номер
unknown
Опубликована: Май 7, 2025
The
detection
of
hyperpolarized
carbon-13
(HP
13C)-fumarate
conversion
to
13C-malate
using
13C-MRSI
is
a
biomarker
for
early
cellular
necrosis.
Here,
we
describe
the
translation
HP
13C-fumarate
as
novel
human
imaging
agent,
including
evaluation
biocompatibility
and
scaling
up
hyperpolarization
methods
clinical
use.
Preclinical
biological
validation
was
undertaken
in
fumarate
hydratase-deficient
murine
tumor
models
controls.
Safety
assessed
healthy
rats
(N
=
18)
volunteers
9).
dissolution
dynamic
nuclear
polarization
process
doses
optimized
phantoms.
Finally,
2D
following
injection
performed
an
ischemia-reperfusion
porcine
kidney
model
6).
Fumarate-to-malate
reduced
by
42%-71%
knockdown
compared
wildtype
tumors.
Twice-daily
at
maximum
evaluated
dose
(120
mg/kg/day)
showed
no
significant
persistent
blood
or
tissue
effects.
Healthy
injected
(3.84
mg/kg)
rate
(5
mL/s)
statistically
changes
vital
signs
measurements
1
h
post-injection.
Spectroscopic
evidence
fumarate-to-malate
observed
ischemic
(0.96
mg/kg).
has
shown
promise
safe
agent
monitoring
This
work
provides
basis
future
metabolism
humans.
Magnetic Resonance in Medicine,
Год журнала:
2022,
Номер
89(1), С. 29 - 39
Опубликована: Сен. 5, 2022
Purpose
To
explore
the
potential
of
deuterium
metabolic
imaging
(DMI)
in
human
brain
vivo
at
7
T,
using
a
multi‐element
(
2
H)
RF
coil
for
3D
volume
coverage.
Methods
1
H‐MR
images
and
localized
H
MR
spectra
were
acquired
3
healthy
subjects
to
generate
DMI
maps
H‐labeled
water,
glucose,
glutamate/glutamine
(Glx).
In
addition,
non‐localized
both
vitro
determine
T
relaxation
times
deuterated
metabolites
T.
The
performance
was
assessed
through
numeric
simulations
experimentally
B
+
maps.
Results
covering
entire
obtained
from
well‐resolved
metabolite
resonances
Glx.
consistent
with
those
reported
adjacent
field
strengths.
Experimental
good
agreement
simulations,
indicating
efficient
homogeneous
transmission
low
power
deposition
H,
similar
array
design
9.4
Conclusion
Here,
we
have
demonstrated
successful
implementation
spatial
temporal
nominal
resolutions
achieved
(i.e.,
2.7
mL
28
min,
respectively)
close
greatly
outperformed
lower
magnetic
fields.
beyond
has
clear
applications
dealing
small
lesions.
Progress in Nuclear Magnetic Resonance Spectroscopy,
Год журнала:
2023,
Номер
134-135, С. 39 - 51
Опубликована: Фев. 10, 2023
Deuterium
metabolic
imaging
(DMI)
is
an
emerging
clinically-applicable
technique
for
the
non-invasive
investigation
of
tissue
metabolism.
The
generally
short
T1
values
2H-labeled
metabolites
in
vivo
can
compensate
relatively
low
sensitivity
detection
by
allowing
rapid
signal
acquisition
absence
significant
saturation.
Studies
with
deuterated
substrates,
including
[6,6′-2H2]glucose,
[2H3]acetate,
[2H9]choline
and
[2,3-2H2]fumarate
have
demonstrated
considerable
potential
DMI
metabolism
cell
death
vivo.
evaluated
here
comparison
established
techniques,
PET
measurements
2-deoxy-2-[18F]fluoro-d-glucose
(FDG)
uptake
13C
MR
hyperpolarized
13C-labeled
substrates.
Magnetic Resonance in Medicine,
Год журнала:
2024,
Номер
91(6), С. 2204 - 2228
Опубликована: Март 5, 2024
Abstract
MRI
with
hyperpolarized
(HP)
13
C
agents,
also
known
as
HP
MRI,
can
measure
processes
such
localized
metabolism
that
is
altered
in
numerous
cancers,
liver,
heart,
kidney
diseases,
and
more.
It
has
been
translated
into
human
studies
during
the
past
10
years,
recent
rapid
growth
largely
based
on
increasing
availability
of
agent
preparation
methods
suitable
for
use
humans.
This
paper
aims
to
capture
current
successful
practices
[1‐
C]pyruvate—by
far
most
commonly
used
agent,
which
sits
at
a
key
metabolic
junction
glycolysis.
The
divided
four
major
topic
areas:
(1)
C‐pyruvate
preparation;
(2)
system
setup
calibrations;
(3)
data
acquisition
image
reconstruction;
(4)
analysis
quantification.
In
each
area,
we
identified
components
study,
summarized
both
published
practices,
discuss
evidence
gaps,
strengths,
limitations.
output
“HP
Consensus
Group”
well
ISMRM
Hyperpolarized
Media
MR
Methods
Equipment
study
groups.
further
provide
comprehensive
reference
future
consensus,
building
field
continues
advance
this
imaging
modality.
Frontiers in Cellular Neuroscience,
Год журнала:
2023,
Номер
17
Опубликована: Апрель 28, 2023
Introduction
There
is
a
lack
of
robust
metabolic
imaging
techniques
that
can
be
routinely
applied
to
characterize
lesions
in
patients
with
brain
tumors.
Here
we
explore
an
animal
model
glioblastoma
the
feasibility
detect
uptake
and
metabolism
deuterated
choline
describe
tumor-to-brain
image
contrast.
Methods
RG2
cells
were
incubated
level
intracellular
its
metabolites
measured
cell
extracts
using
high
resolution
1
H
NMR.
In
rats
orthotopically
implanted
tumors
deuterium
(DMI)
was
vivo
during,
as
well
day
after,
intravenous
infusion
2
9
-choline.
parallel
experiments,
RG2-bearing
infused
[1,1′,2,2′-
4
]-choline
tissue
metabolite
analyzed
NMR
identify
molecule-specific
H-labeling
metabolites.
Results
vitro
experiments
indicated
fast
phosphorylation
exogenous
cells.
DMI
studies
revealed
signal
from
H-labeled
pool
+
(total
choline,
H-tCho)
tumor
lesion
but
not
normal
brain.
Quantitative
DMI-based
maps
H-tCho
showed
contrast
acquired
both
24
h
after
infusion.
High
data
during
H-choline
consists
free
phosphocholine,
while
later
represent
phosphocholine
glycerophosphocholine.
Discussion
Uptake
compared
brain,
resulting
on
maps.
By
varying
timing
acquisition
relative
start
infusion,
weighted
toward
detection
or
metabolism.
These
proof-of-principle
highlight
potential
combined
metabolically
Deuterium
(2H)
MRI
is
an
emerging
tool
for
noninvasive
imaging.
We
explore
the
integration
of
2H
with
deuterated
multifunctional
nanopolymers
particle
imaging
(DPI).
To
this
end,
amine-terminated
G5-polyamidoamine
(PAMAM)
dendrimers
were
labeled
acetyl
surface
groups,
leading
to
highly
2H-loaded
bioparticles,
making
them
ideal
studies.
The
accumulation
∼5
nm
PAMAM
in
kidneys
could
then
be
seen
by
high
submillimeter
resolution.
natural
abundance
HDO
signal
provided
internal
concentration
reference
these
measurements,
quantitative
dynamic
maps
showing
distinct
nanopolymer
uptakes
within
renal
compartments.
Further,
allowed
us
obtain
vivo
activity
lymph
nodes
inflammatory
rodent
leg
model,
demonstrating
nanopolymers'
potential
as
a
novel
class
contrast
agents
mapping
physiological
processes.
Investigative Radiology,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 14, 2025
Objectives
The
aim
of
the
study
was
to
translate
abdominal
deuterium
metabolic
imaging
(DMI)
clinical
field
strength
by
optimizing
radiofrequency
coil
setup,
administered
dose
(
2
H)-labeled
glucose,
and
data
processing
pipeline
for
quantitative
characterization
DMI
signals
over
time.
This
assessed
in
kidney
liver
establish
a
basis
routine
studies
future.
Materials
Methods
5
healthy
volunteers
were
recruited
imaged
on
or
3
separate
occasions,
with
varying
doses
H-glucose:
0.75
g/kg
(high
dose),
0.50
(medium
0.25
(low
resulting
total
13
scan
sessions.
performed
at
T
using
flexible
20
×
30
cm
H-tuned
transmit-receive
surface
coil.
For
comparisons
across
scans,
H-glucose
signal
normalized
against
sum
H-water
(GGW
ratio).
To
quantify
time
course
GGW,
novel
metrics
metabolism
defined
compared
between
organs:
maximum
value
max
),
whole
AUC
average
plateau
mean
).
H-lipid
overlaps
H-lactate;
hence,
measured
as
combined
H-lipid+lactate
signal.
Results
careful
positioning
dedicated
minimized
unwanted
gastric
while
maintaining
excellent
hepatic
renal
measurements.
courses
derived
from
reproducible
comparable
different
doses,
showing
potential
reduction.
plateaued
approximately
minutes,
that
40
minutes.
exhibited
higher
values
uptake
kidney,
trend
consistent
all
example,
highest
dose:
GGW
=
31
±
3;
27
P
0.05.
A
toward
lower
measurements
decreasing
observed:
this
significant
high
low
parameters
medium
,
but
not
any
parameters.
increased
70–90
minutes
12/13
cases
(mean:
39
24%),
lipid+lactate
only
8/13
17%).
18
10%),
10/13
10
13%).
Conclusions
human
abdomen
is
feasible
magnetic
resonance
system
changes
can
serve
reference
future
studies.
be
reduced
minimize
without
substantially
affecting
reliability
organ
quantification.
increase
could
direct
indirect
measures
metabolism,
respectively.
Magnetic Resonance in Medicine,
Год журнала:
2023,
Номер
91(1), С. 39 - 50
Опубликована: Окт. 5, 2023
Abstract
Purpose
To
explore
the
potential
of
3T
deuterium
metabolic
imaging
(DMI)
using
a
birdcage
2
H
radiofrequency
(RF)
coil
in
both
healthy
volunteers
and
patients
with
central
nervous
system
(CNS)
lesions.
Methods
A
modified
gradient
filter,
home‐built
volume
RF
coil,
spherical
k‐space
sampling
were
employed
three‐dimensional
chemical
shift
acquisition
to
obtain
high‐quality
whole‐brain
images
H‐labeled
water
glucose
products.
These
acquired
volunteer
three
subjects
CNS
lesions
varying
pathologies.
Hardware
pulse
sequence
experiments
also
conducted
improve
signal‐to‐noise
ratio
DMI
at
3T.
Results
The
ability
quantify
local
metabolism
correspondence
anatomical
landmarks
across
is
demonstrated,
increased
lactate
observed
one
patient
most
active
disease.
Conclusion
offers
examine
activity
human
3T,
promising
for
future
clinical
translation
this
technique.
Molecular Imaging and Biology,
Год журнала:
2023,
Номер
26(2), С. 222 - 232
Опубликована: Дек. 26, 2023
Abstract
Hyperpolarization
techniques
significantly
enhance
the
sensitivity
of
magnetic
resonance
(MR)
and
thus
present
fascinating
new
directions
for
research
applications
with
in
vivo
MR
imaging
spectroscopy
(MRI/S).
Hyperpolarized
13
C
MRI/S,
particular,
enables
real-time
non-invasive
assessment
metabolic
processes
holds
great
promise
a
diverse
range
clinical
spanning
fields
like
oncology,
neurology,
cardiology,
potential
improving
early
diagnosis
disease,
patient
stratification,
therapy
response
assessment.
Despite
its
potential,
technical
challenges
remain
achieving
translation.
This
paper
provides
an
overview
discussions
that
took
place
at
international
workshop
“New
Horizons
MRI,”
March
2023
Bavarian
Academy
Sciences
Humanities,
Munich,
Germany.
The
covered
developments,
as
well
future
directions,
topics
including
polarization
(particularly
focusing
on
parahydrogen-based
methods),
novel
probes,
considerations
related
to
data
acquisition
analysis,
emerging
oncology
other
fields.
Abstract
The
challenge
in
clinical
oncology
is
to
select
the
most
appropriate
treatment
for
an
individual
patient.
Transcriptome
and
metabolite
profiling
have
revealed
that
tumours
can
display
metabolic
subtypes
with
different
therapeutic
vulnerabilities
1–4
.
Metabolic
imaging
has
potential
distinguish
these
therefore
those
treatment(s)
should
be
effective.
Moreover,
since
changes
tumour
metabolism
occur
early
during
treatment,
also
used
subsequently
detect
evidence
of
response.
In
this
Perspective
I
briefly
review
discuss
relative
advantages
disadvantages
magnetic
resonance
using
hyperpolarized
13
C-
2
H-labelled
substrates.